ROCKVILLE, Md., April 5, 2024 /PRNewswire/ — I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.
23rd Annual Needham Virtual Healthcare Conference
Presentation Time
Thursday, April 11 at 10:15 a.m. EST
Presenters
Raj Kannan, CEO; John Hayslip CMO
Webcast link
Meetings
One-on-one and small group meetings: April 11, 2024
ManagementParticipants
Raj Kannan, CEO
Joe Skelton, CFO
John Hayslip, CMOTyler Ehler, Senior Director, Investor Relations
The webcast will also be available under "Event Calendar" on I-Mab’s IR websiteat http://ir.i-mabbiopharma.com/
For more information, please contact your Needham representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit http://www.i-mabbiopharma.com and follow us on LinkedIn and X.
For more information, please contact:Tyler EhlerSenior Director, Investor RelationsIR@imabbio.com
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
